BIB vs VXUS
ProShares Ultra Nasdaq Biotechnology vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. BIB delivered stronger 1-year returns. VXUS offers more diversification with 8,747 holdings.
Side-by-Side Comparison
| Metric | BIB | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.95% | 0.05% | |
| AUM | $88M | $158.1B | |
| Dividend Yield | 0.33% | 2.59% | |
| Holdings | 261 | 8,747 | |
| YTD Return | +34.21% | +15.22% | |
| 1Y Return | +95.96% | +26.86% | |
| 3Y Return (annualized) | +28.37% | +20.34% | |
| 5Y Return (annualized) | +2.01% | +9.38% | |
| Volatility (annualized) | 40.4% | 15.1% | |
| Max Drawdown | -67.2% | -39.9% | |
| Fund Family | ProShares | Vanguard (US) | |
| Category | Alternative | Equity | |
| Inception | Apr 6, 2010 | Jan 26, 2011 |
BIB vs VXUS Performance
ProShares Ultra Nasdaq Biotechnology (BIB) is a ETF from ProShares and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year BIB returned +95.96% while VXUS returned +26.86%. Year to date, BIB is up 34.21% versus a gain of 15.22% for VXUS.
Over three years, BIB compounded at +28.37% per year against +20.34% for VXUS; over five years the annualized figures are +2.01% and +9.38% respectively. Across the full 16-year window we track, BIB has the edge at +17.83% annualized vs +4.89%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BIB has been the more volatile fund, with annualized monthly volatility of 40.4% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -67.2% for BIB and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.53. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
BIB charges 0.95% per year while VXUS charges 0.05%. On a $10,000 position that is $95 vs $5 annually, a gap of $90 per year that compounds over a long holding period. On income, BIB currently yields 0.33% against 2.59% for VXUS.
Holdings Overlap
BIB and VXUS share 4 holdings out of 8117 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, BIB or VXUS?
BIB has an expense ratio of 0.95% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $90 per year of difference.
Which performed better, BIB or VXUS?
Over the past year BIB returned +95.96% vs +26.86% for VXUS, so BIB leads on 1-year performance. Over the longest common window we track (16 years), BIB annualized +17.83% vs +4.89% for VXUS. Past performance does not guarantee future results.
Which is riskier, BIB or VXUS?
BIB has been the more volatile fund at 40.4% annualized versus 15.1% for VXUS. Worst drawdown: BIB -67.2% vs VXUS -39.9%.
Should I hold both BIB and VXUS?
BIB and VXUS have a monthly-return correlation of 0.53, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between BIB and VXUS?
BIB and VXUS share 4 common holdings with a 0.0% weight overlap. Combined, they hold 8117 unique securities.
Which pays a higher dividend, BIB or VXUS?
BIB yields 0.33% while VXUS yields 2.59%, so VXUS currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.